MYH11 was one of the most significant differentially expressed GOI, differing significantly when comparing intermediate and good risk (p = 1.74 × 10−15) and poor and good risk adults with AML (p = 6.70 × 10−6). Here, MYH11 is linked to acute myeloid leukemia.